MedTrace Logo

Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls

NCT01860963 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2013-10-01

No results posted yet for this study

Summary

This study is designed to establish the prevalence of anal squamous intraepithelial lesion (ASIL) in patients with inflammatory bowel disease (IBD) and healthy controls.

Conditions

  • Anal Squamous Intraepithelial Lesion (ASIL)
  • HPV DNA

Interventions

PROCEDURE

Anal Pap smear and HPV DNA testing

Anal Pap smear is a standard diagnostic test used for early detection of pre-cancerous cells and anal HPV.

Sponsors & Collaborators

Principal Investigators

  • Mark Welton, MD · Stanford Hosptial and Clinics

  • Shamita Shah, MD · Stanford Hospital and Clinics

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01860963 on ClinicalTrials.gov